Exclusivity Information
Mometamax Single holds 1 exclusivity out of which 0 have expired. Its last outstanding exclusivity is set to expire in 2028. Details of Mometamax Single's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Apr 29, 2028 |
About Mometamax Single
Mometamax Single is a drug
owned by INTERVET, INC.
Mometamax Single uses
Gentamicin, Mometasone Furoate, Posaconazole as the active
ingredients.
Active Ingredient:
Mometamax Single uses
Gentamicin,
Mometasone Furoate, Posaconazole
as the active ingredients.
Check out other Drugs and Companies using
Gentamicin, Mometasone Furoate, Posaconazole ingredient.